| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Oyler John serves as a Chief Executive Officer at BEIGF and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 464 sells.
Historically, Oyler John's trades have earned a middling insider score of 58/100 across 45 rated trades. Over a 12-month horizon, 51.4% of those trades were profitable, with an average 12-month return of +4.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell10b5-1 | 109,090 | $306.33 | $33,417,381.16 | -100% | -4.8% | - | |
| Sep 16, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell10b5-1 | 27,803 | $325.71 | $9,055,693.88 | -100% | -5.1% | +6.4% | |
| Jul 9, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell10b5-1 | 27,802 | $253.38 | $7,044,590.88 | -100% | +33.6% | - | |
| Jun 23, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 3,174 | $261.61 | $830,359.87 | -100% | +31.2% | +4.9% | |
| Jun 17, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 5,140 | $263.33 | $1,353,519.55 | -100% | +30.8% | +4.1% | |
| Jun 6, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 5,127 | $252.77 | $1,295,946.05 | -100% | +24.6% | - | |
| Mar 10, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 41,210 | $242.67 | $10,000,482.50 | - | +8.7% | +25.9% | |
| Mar 7, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 57,380 | $249.34 | $14,307,097.14 | - | +4.0% | +21.9% | |
| Mar 6, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 40,109 | $259.15 | $10,394,328.73 | - | +0.5% | +17.2% | |
| Mar 3, 2025 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sale+OE | 101,000 | $244.30 | $24,674,638.28 | - | +0.2% | +21.0% |